Literature DB >> 19898702

Treatment delay in ST elevation myocardial infarction care in a community hospital -- a cautionary tale.

J Ducas, W J Cantor.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19898702      PMCID： PMC2776569          DOI： 10.1016/s0828-282x(09)70166-7

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  19 in total

1.  A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Timothy D Henry; Scott W Sharkey; M Nicholas Burke; Ivan J Chavez; Kevin J Graham; Christopher R Henry; Daniel L Lips; James D Madison; Katie M Menssen; Michael R Mooney; Marc C Newell; Wes R Pedersen; Anil K Poulose; Jay H Traverse; Barbara T Unger; Yale L Wang; David M Larson
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

2.  A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.

Authors:  Paul W Armstrong
Journal:  Eur Heart J       Date:  2006-06-06       Impact factor: 29.983

3.  Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.

Authors:  Henry H Ting; Charanjit S Rihal; Bernard J Gersh; Luis H Haro; Christine M Bjerke; Ryan J Lennon; Choon-Chern Lim; John F Bresnahan; Allan S Jaffe; David R Holmes; Malcolm R Bell
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

4.  Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.

Authors: 
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

5.  The open-artery theory is alive and well--again.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

6.  Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study).

Authors:  Michel R Le May; George A Wells; Marino Labinaz; Richard F Davies; Michele Turek; Danielle Leddy; Justin Maloney; Tim McKibbin; Brendan Quinn; Rob S Beanlands; Chris Glover; Jean-François Marquis; Edward R O'Brien; William L Williams; Lyall A Higginson
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

7.  Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.

Authors:  John K French; Henry A Feldman; Susan F Assmann; Timothy Sanborn; Sebastian T Palmeri; David Miller; Jean Boland; Christopher E Buller; Richard Steingart; Lynn A Sleeper; Judith S Hochman
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

8.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

Authors:  Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-03-09       Impact factor: 91.245

9.  Routine early angioplasty after fibrinolysis for acute myocardial infarction.

Authors:  Warren J Cantor; David Fitchett; Bjug Borgundvaag; John Ducas; Michael Heffernan; Eric A Cohen; Laurie J Morrison; Anatoly Langer; Vladimir Dzavik; Shamir R Mehta; Charles Lazzam; Brian Schwartz; Amparo Casanova; Shaun G Goodman
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

10.  Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

Authors:  Frans Van de Werf; Jeroen Bax; Amadeo Betriu; Carina Blomstrom-Lundqvist; Filippo Crea; Volkmar Falk; Gerasimos Filippatos; Keith Fox; Kurt Huber; Adnan Kastrati; Annika Rosengren; P Gabriel Steg; Marco Tubaro; Freek Verheugt; Franz Weidinger; Michael Weis
Journal:  Eur Heart J       Date:  2008-11-12       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.